» Articles » PMID: 37052678

Time to Negative Throat Culture Following Initiation of Antibiotics for Pharyngeal Group A : a Systematic Review and Meta-analysis Up to October 2021 to Inform Public Health Control Measures

Overview
Journal Euro Surveill
Date 2023 Apr 13
PMID 37052678
Authors
Affiliations
Soon will be listed here.
Abstract

BackgroundPublic health guidance recommending isolation of individuals with group A streptococcal (GAS) infection or carriage for 12-24 h from antibiotic initiation to prevent onward transmission requires a strong evidence base.AimTo estimate the pooled proportion of individuals who remain GAS culture-positive at set intervals after initiation of antibiotics through a systematic literature review (PROSPERO CRD42021290364) and meta-analysis.MethodsWe searched Ovid MEDLINE (1946-), EMBASE (1974-) and Cochrane library. We included interventional or observational studies with ≥ 10 participants reporting rates of GAS throat culture positivity during antibiotic treatment for culture-confirmed GAS pharyngitis, scarlet fever and asymptomatic pharyngeal GAS carriage. We did not apply age, language or geographical restrictions.ResultsOf 5,058 unique records, 43 were included (37 randomised controlled studies, three non-randomised controlled trials and three before-and-after studies). The proportion of individuals remaining culture-positive on day 1, day 2 and days 3-9 were 6.9% (95% CI: 2.7-16.8%), 5.4% (95% CI: 2.1-13.3%) and 2.6% (95% CI: 1.6-4.2%). For penicillins and cephalosporins, day 1 positivity was 6.5% (95% CI: 2.5-16.1%) and 1.6% (95% CI: 0.04-42.9%), respectively. Overall, for 9.1% (95% CI: 7.3-11.3), throat swabs collected after completion of therapy were GAS culture-positive. Only six studies had low risk of bias.ConclusionsOur review provides evidence that antibiotics for pharyngeal GAS achieve a high rate of culture conversion within 24 h but highlights the need for further research given methodological limitations of published studies and imprecision of pooled estimates. Further evidence is needed for non-beta-lactam antibiotics and asymptomatic individuals.

Citing Articles

Risk Factors for Acute Rheumatic Disease: Exploring Factors at Individual and Collective Levels.

Mendoza R, Mutarelli A, Mendoza B, Barbosa J, Oliveira R, Nascimento B Rev Soc Bras Med Trop. 2024; 57.

PMID: 39570153 PMC: 11654748. DOI: 10.1590/0037-8682-0139-2024.


Treatment of recurrent acute tonsillitis-a systematic review and clinical practice recommendations.

Guntinas-Lichius O, Geissler K, Makitie A, Ronen O, Bradley P, Rinaldo A Front Surg. 2023; 10:1221932.

PMID: 37881239 PMC: 10597714. DOI: 10.3389/fsurg.2023.1221932.

References
1.
Sinanian R, Ruoff G, Panzer J, Atkinson W . Streptococcal pharyngitis: a comparison of the eradication of the organism by 5- and 10-day antibiotic therapy. Curr Ther Res Clin Exp. 1972; 14(11):716-20. View

2.
Steer J, Lamagni T, Healy B, Morgan M, Dryden M, Rao B . Guidelines for prevention and control of group A streptococcal infection in acute healthcare and maternity settings in the UK. J Infect. 2011; 64(1):1-18. DOI: 10.1016/j.jinf.2011.11.001. View

3.
. Interim UK guidelines for management of close community contacts of invasive group A streptococcal disease. Commun Dis Public Health. 2005; 7(4):354-61. View

4.
Snellman L, Stang H, Stang J, Johnson D, Kaplan E . Duration of positive throat cultures for group A streptococci after initiation of antibiotic therapy. Pediatrics. 1993; 91(6):1166-70. View

5.
Stillerman M . Comparison of oral cephalosporins with penicillin therapy for group A streptococcal pharyngitis. Pediatr Infect Dis. 1986; 5(6):649-54. DOI: 10.1097/00006454-198611000-00010. View